Search

Search Constraints

You searched for: Author/Creator Stoops, Erik

Search Results

11. [P4–469]: USE FOR CALIBRATION OF CERTIFIED REFERENCE MATERIALS FOR Aβ1–42. (1st July 2017)

12. A head‐to‐head comparison of plasma phosphorylated tau assays in the real‐world memory clinic. (20th December 2022)

14. Amyloid‐βeta peptides in CSF and plasma discriminate cerebral amyloid angiopathy from controls. (1st February 2022)

15. Amyloid‐βeta peptides in CSF and plasma discriminate cerebral amyloid angiopathy from controls. (December 2021)

16. Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study. Issue 1 (13th November 2018)

17. Automation on an Open-Access Platform of Alzheimer's Disease Biomarker Immunoassays. (April 2018)

18. Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo. Issue 1 (27th August 2021)

19. Cerebrospinal fluid biomarker levels are not affected by aspiration or gravity drip extraction methods in Alzheimer's disease: The AIBL study: Biomarkers (non‐neuroimaging): Method development and validation. (7th December 2020)

20. Cerebrospinal fluid levels of synaptic and neuronal integrity correlate with gray matter volume and amyloid load in the precuneus of cognitively intact older adults. Issue 1 (20th March 2019)